about
Comparison of clinical data sets acquired on different tomographs using 6-18F-L-dopa.Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD).Rest tremor and extrapyramidal symptoms after midbrain haemorrhage: clinical and 18F-dopa PET evaluation.Behavioral and neural correlates of communication via pointingEffect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study.Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial.Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease.pH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study.Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior.Automatic segmentation of the striatum and globus pallidus using MIST: Multimodal Image Segmentation ToolCan nicotine be used medicinally in Parkinson's disease?Biotherapies for Parkinson disease.Executive functions deficit in mild cognitive impairment.The neural substrates of script knowledge deficits as revealed by a PET study in Huntington's disease.In vivo evidence for the selective subcortical degeneration in Huntington's disease.MRI-stereotactical approach for neural grafting in basal ganglia disorders.Case report of pallido-pyramidal disease with supplementary motor area involvement.Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study.Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue.Striatal neural grafting improves cortical metabolism in Huntington's disease patients.Functional recovery in a primate model of Parkinson's disease following motor cortex stimulation.Language processing within the striatum: evidence from a PET correlation study in Huntington's disease.Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease.Motor and cognitive improvements in patients with Huntington's disease after neural transplantation.Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study.Biotherapies in brain diseases: for who, when and how?Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia.HIV-related nephropathies associated with changes in blood and kidney tissue virus load.A multitracer dopaminergic PET study of young-onset parkinsonian patients with and without parkin gene mutations.Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease.[Biotherapies and Parkinson's disease].Viewing another person's body as a target object: a behavioural and PET study of pointing.Contrasting changes in cortical activation induced by acute high-frequency stimulation within the globus pallidus in Parkinson's disease.Movement- and task-related activations of motor cortical areas: a positron emission tomographic study.Dopaminergic dysfunction in midbrain dystonia: anatomoclinical study using 3-dimensional magnetic resonance imaging and fluorodopa F 18 positron emission tomography.Optimized Quantification of Translocator Protein Radioligand ¹⁸F-DPA-714 Uptake in the Brain of Genotyped Healthy Volunteers.Clinical routine use of dopamine transporter imaging in 516 consecutive patients.Chronic systemic treatment with a high-dose proteasome inhibitor in mice produces akinesia unrelated to nigrostriatal degeneration.PET study and neuropsychological assessment of a long-lasting post-encephalitic parkinsonism.
P50
Q31791110-8E848E10-3721-4D00-8CB9-14A8994DA483Q33704308-01BB7FBD-EF98-4E69-BA29-DF1F6A4F491FQ33732946-6D98CB4B-359B-40C0-92FE-00FD60CA7A97Q33851445-71BF0DEB-16E7-41C0-B589-94991DE91FC1Q33994217-93A40522-5922-44AD-B7D1-99D7BCF079C8Q34397099-61A63021-D46A-4BA7-8E3F-E03893BB9FA9Q35575249-5A3F7354-42CE-4377-99BD-F8B8F561E1DDQ35939218-BF7DE326-DAC5-4094-A8FA-511D42BF3D88Q35973431-BEA5EE74-B3D3-44CD-A5FC-D7900B39B428Q36408075-6F0B2A6E-D343-487B-8D2F-A1254D6C0642Q37960523-CE0AD057-BAD1-452C-874F-86143F883ED7Q38280245-F1E35542-53D5-4DCC-8576-FC43938E90FEQ38393220-5B33273D-510C-4417-8E57-E88190259707Q38489850-82DCA025-D3CE-4E5D-8401-4EB2F16EA502Q39991119-BBA503D1-C520-4CE8-81BB-6E9A442100BAQ42453128-432E2648-F83F-447B-A451-032191D077D6Q43693361-AC16EE87-2C6F-4FFA-9A88-9D0667CF350BQ44447062-527F215B-BC15-478D-A8B7-ED87F5535C19Q44499883-8F59D011-F933-496A-9CD9-00EC2FEC55CDQ44531224-F4011FFF-2ACF-4EAE-9345-5E6F9FE4E2E4Q44649029-D1121B44-F22A-4F23-933A-B06992F28810Q45168491-AE7154FC-56E6-4421-B184-BCC275C400B5Q45288906-CE341904-251D-4D5B-B529-4644C6520EA5Q45299926-4455ACAA-C162-49CD-B3B8-BA91DB7E17DCQ45301920-1BEA8726-00A5-453A-B8DF-94AF46B5F50EQ45302010-4329365D-0DC6-4147-8702-2080B427394AQ45302989-029E35DA-1810-43D1-8D09-7A86640DB134Q45368453-79ADD7EA-59A9-46CC-B36E-46E0F43963D2Q45397911-8F2142F0-07E9-4B15-A023-CE4E03267886Q45925587-A109B79F-1A9C-4DFB-AD7C-48F032D95DEBQ45985006-303EBF84-D2EF-4174-BF40-24837D4ABAC9Q45987420-523CA5FF-E104-4A56-B36E-F78AA6CD738FQ47204379-EBB6D48C-8635-45C4-8523-B23A279D53FDQ47355738-9FAA01F3-E960-4BAD-BCAE-BC0B72DA54B2Q48093953-0CB1BFAC-254F-49F8-966A-1608C590369AQ48135469-E8A8B5E6-0C14-46C2-B637-FBFBA5B1DC1AQ48153600-AB7701C9-E4DD-49B1-B1BA-2872F8FBFD61Q48345075-CC8BF985-C598-457B-8212-AE87F73951CEQ48375905-C41227B1-FF77-4ECF-A186-E8B0089B35A1Q48404167-DACDD424-32E9-43C3-9ED6-0F42A1F2A266
P50
description
chercheur
@fr
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Philippe Remy
@af
Philippe Remy
@an
Philippe Remy
@ast
Philippe Remy
@bar
Philippe Remy
@br
Philippe Remy
@ca
Philippe Remy
@co
Philippe Remy
@cs
Philippe Remy
@cy
Philippe Remy
@da
type
label
Philippe Remy
@af
Philippe Remy
@an
Philippe Remy
@ast
Philippe Remy
@bar
Philippe Remy
@br
Philippe Remy
@ca
Philippe Remy
@co
Philippe Remy
@cs
Philippe Remy
@cy
Philippe Remy
@da
altLabel
P Remy
@en
P Rémy
@en
Philippe Rémy
@en
Remy P
@en
prefLabel
Philippe Remy
@af
Philippe Remy
@an
Philippe Remy
@ast
Philippe Remy
@bar
Philippe Remy
@br
Philippe Remy
@ca
Philippe Remy
@co
Philippe Remy
@cs
Philippe Remy
@cy
Philippe Remy
@da
P106
P1153
56443695600
P21
P31
P4012
P496
0000-0003-2150-2563